Reduced SHBG and IGF, preferentially insulin-like growth factor-binding protein 1 (IGFBP-1, also known as placental protein 12 or PP12), have been reported to be associated with hyperinsulinemia and represented as critical biomarkers/indicators of the metabolic syndrome [142]. This evidence concerns the gene IGFBP1 and metabolic syndrome.